product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human MCM2
catalog :
MCA1859
quantity :
0.1 mg
price :
264 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CRCT2.1
reactivity :
human
application :
western blot
more info or order :
citations: 3
| Published Application/Species/Sample/Dilution | Reference |
|---|---|
| |
Gakiopoulou H, Korkolopoulou P, Levidou G, Thymara I, Saetta A, Piperi C, et al. Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications. Br J Cancer. 2007;97:1124-34 pubmed
|
image
image 1 :
Paraffin embedded human tonsil stained with Mouse anti Human MCM2 (MCA1859) following citrate antigen retrieval
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA1859
Description :
Mouse anti Human MCM2
Specificity :
MCM2
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,P
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin
Clone :
CRCT2.1
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0000075,GO:0000082,GO:0000084,GO:0005515,GO:0000216,GO:0000785,GO:0046872,GO:0005524,GO:0005654,GO:0006270,GO:0006271,GO:0006350,GO:0045449
GOTerms :
cell cycle checkpoint,G1/S transition of mitotic cell cycle,S phase of mitotic cell cycle,protein binding,M/G1 transition of mitotic cell cycle,chromatin,metal ion binding,ATP binding,nucleoplasm,DNA-dependent DNA replication initiation,DNA strand elongation involved in DNA replication,transcription,regulation of transcription
Uniprot Accessions :
P49736
Gene :
MCM2
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4171
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
189
PriceEUR :
264
PriceUSD :
264 USD
PriceCHF :
287
PriceSEK :
2878
PriceNOK :
2892
PriceDKK :
1968
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.